14 reports

  • GLOBAL SEXUAL DYSFUNCTION DRUGS MARKET SEGMENTATION BY THERAPY 2016
  • GLOBAL SEXUAL DYSFUNCTION DRUGS MARKET 2016-2021 ($ MILLIONS)

About Sexual Dysfunction Drugs Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in...

  • Dysfunction Drug
  • World
  • AbbVie Inc.
  • Eli Lilly & Co.
  • Pfizer Inc.

The 2019-2024 World Outlook for Erectile Dysfunction Drugs ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Dysfunction Drug
  • Therapy
  • World
  • Demand

Male and Female Sexual Dysfunctions: Drug Market Report and Forecasts 2016-2026 ##.

  • Dysfunction Drug
  • Pharmaceutical
  • Therapy
  • World
  • Market Size
  • Increasing Demand For Low-Cost Erectile Dysfunction Drugs
  • Demand For Combination Products

The genitourinary drugs market covers drugs that are used in the treatment of diseases such as urinary tract infections, male reproductive diseases, voiding diseases, female reproductive diseases, glomerular disorders, urinary calculi, cystic kidney disease, Reno vascular diseases, benign prostate diseases, and other related diseases. North...

  • Dysfunction Drug
  • World
  • Bayer AG
  • Daiichi Sankyo Company
  • Pfizer Inc.
  • Increasing Demand For Low-Cost Erectile Dysfunction Drugs
  • Demand For Combination Products

The genitourinary drugs market covers drugs that are used in the treatment of diseases such as urinary tract infections, male reproductive diseases, voiding diseases, female reproductive diseases, glomerular disorders, urinary calculi, cystic kidney disease, Reno vascular diseases, benign prostate diseases, and other related diseases. The...

  • Dysfunction Drug
  • World
  • Bayer AG
  • Daiichi Sankyo Company
  • Pfizer Inc.
  • 21.3 ERECTILE DYSFUNCTION DRUGS MARKET
  • 22.3 ERECTILE DYSFUNCTION DRUGS MARKET

This market research report on the erectile dysfunction market offers analysis on market size and forecast, market share, industry trends, growth drivers, and vendor analysis. The study also includes insights on segmentation by therapy type (drug therapies and device therapies) and geography (APAC, Europe, Latin America, MEA, and North America). Erectile...

  • Dysfunction Drug
  • World
  • Forecast
  • Market Size
  • Pfizer Inc.
  • Female Sexual Dysfunction - Drug Profiles
  • SMALL MOLECULE FOR SEXUAL DYSFUNCTION - DRUG PROFILE

Female Sexual Dysfunction - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Female Sexual Dysfunction - Pipeline Review, H2 2017, provides an overview of the Female Sexual Dysfunction (Women’s Health) pipeline landscape. Female...

  • Dysfunction Drug
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • Female Sexual Dysfunction - Drug Profiles
  • SMALL MOLECULE FOR SEXUAL DYSFUNCTION - DRUG PROFILE

Female Sexual Dysfunction - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Female Sexual Dysfunction - Pipeline Review, H1 2017, provides an overview of the Female Sexual Dysfunction (Women’s Health) pipeline landscape. Female sexual dysfunction...

  • Dysfunction Drug
  • United States
  • Litigation And Patent
  • Product Initiative
  • Palatin Technologies, Inc.
  • Erectile Dysfunction - Drug Profiles
  • SMALL MOLECULE TO INHIBIT PDE5 FOR ERECTILE DYSFUNCTION - DRUG PROFILE

Erectile Dysfunction - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Erectile Dysfunction - Pipeline Review, H1 2018, provides an overview of the Erectile Dysfunction (Male Health) pipeline landscape. Erectile dysfunction,...

  • Dysfunction Drug
  • Pharmaceutical
  • United States
  • Product Initiative
  • Apricus Biosciences, Inc.
  • Erectile Dysfunction - Drug Profiles
  • SMALL MOLECULE TO INHIBIT PDE5 FOR ERECTILE DYSFUNCTION - DRUG PROFILE

Erectile Dysfunction - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Erectile Dysfunction - Pipeline Review, H2 2017, provides an overview of the Erectile Dysfunction (Male Health) pipeline landscape. Erectile dysfunction, or ED, is the inability...

  • Dysfunction Drug
  • Pharmaceutical
  • United States
  • Product Initiative
  • Apricus Biosciences, Inc.
  • Global ED treatment market by product 2015 and 2020
  • Global ED treatment market by product 2015-2020

About Erectile Dysfunction The loss of erection can be attributed to various factors such as high blood pressure, aging, diabetes mellitus, smoking, alcoholism, depression, nerve or spinal cord damage, and low testosterone levels. The condition can be treated with a broad range of drugs and implants available in the market. Technavio’s...

  • Dysfunction Drug
  • Boston Scientific Corporation
  • Coloplast Group
  • Eli Lilly & Co.
  • Pfizer Inc.
  • 8.2.1 FEATURED NEWS & PRESS RELEASES

PHEONIX IS HALAL-CERTIFIED AND ONE OF SEVERAL OTHER DRUGS IN IX BIOPHARMA' S PRODUCT PIPELINE.

  • Dysfunction Drug
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative
  • R&D Progress

The drug candidate acts by agonizing the melanocortin receptor-## (MC##R).

  • Dysfunction Drug
  • Therapy
  • United States
  • Company Operations
  • Palatin Technologies, Inc.

Drug A: Company ## ##. ##. ##.

  • Dysfunction Drug
  • Therapy
  • United States
  • Market Shares